GABAA受体抗体相关脑炎的临床研究
该研究纳入26例抗GABAA受体脑炎患者,其中17例为新诊断病例。常见症状为癫痫发作(88%)和认知改变(67%),88%患者MRI异常,表现为多灶性皮质-皮质下T2/FLAIR异常。免疫或肿瘤治疗后86%可评估患者显著改善,14%死亡。儿童与成人症状及合并症不同。
要点
- 抗GABAA受体脑炎以频繁癫痫发作和特征性多灶性MRI异常为特点。
- 儿童更易出现全面性发作和运动障碍,成人更易合并肿瘤。
- 多数患者对免疫或肿瘤治疗反应良好,但病情严重,部分可致死。
核心结论
- 抗GABAA受体脑炎以频繁癫痫发作和特征性多灶性皮质-皮质下MRI异常为特征,是重要诊断线索。
- 儿童与成人症状及合并症频率不同:儿童更多病毒相关,成人更多肿瘤相关。
- 该病严重,但多数患者对治疗有反应。
研究设计与样本
- 临床研究,纳入26例患者,包括17例新诊断(2013年4月至2016年1月)和9例既往报道患者。
- 采用已报道技术检测GABAA受体α1、β3和γ2亚基抗体。
主要发现
- 患者中位年龄40.5岁(四分位距48.5 [13.75-62.35]岁;最小2.5个月;13例女性)。
- 症状包括癫痫发作(88%)、认知改变(67%)、行为异常(46%)、意识改变(42%)和异常运动(35%)。
- 11例(42%)患者存在合并症,包括7例肿瘤(多为胸腺瘤)、2例疱疹病毒脑炎(HSV-1、HHV-6,合并NMDAR抗体)和2例无胸腺瘤的重症肌无力。
- 23例(88%)患者脑MRI异常,20例(77%)表现为多灶性、非同步性皮质-皮质下T2/FLAIR异常,主要累及颞叶(95%)和额叶(65%),也累及基底节和其他区域。
- 免疫或肿瘤治疗后,18/21(86%)可评估患者显著改善,其余3例(14%)死亡(2例癫痫持续状态,1例脓毒症)。
关键数值与推荐
- 与成人相比,儿童更易出现全面性发作(p = 0.007)和运动障碍(p = 0.01),更少合并肿瘤(p = 0.01)。
- 主要表位靶点为GABAA受体的α1/β3亚基。
临床怎么用
- 对频繁癫痫发作且MRI显示多灶性皮质-皮质下异常的患者,应考虑检测GABAA受体抗体。
- 儿童患者需注意病毒相关病因,成人患者需筛查肿瘤。
- 治疗应采用免疫或肿瘤导向治疗,多数患者可显著改善。
局限性
- 样本量较小(26例),部分为既往报道病例。
- 为观察性临床研究,非随机对照设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the clinical features, comorbidities, receptor subunit targets, and outcome in patients with anti-GABAA receptor (GABAAR) encephalitis. METHODS: Clinical study of 26 patients, including 17 new (April 2013-January 2016) and 9 previously reported patients. Antibodies to α1, β3, and γ2 subunits of the GABAAR were determined using reported techniques. RESULTS: Patients' median age was 40.5 years (interquartile range 48.5 [13.75-62.35] years; the youngest 2.5 months old; 13 female). Symptoms included seizures (88%), alteration of cognition (67%), behavior (46%), consciousness (42%), or abnormal movements (35%). Comorbidities were identified in 11 (42%) patients, including 7 tumors (mostly thymomas), 2 herpesvirus encephalitis (herpes simplex virus 1, human herpesvirus 6; coexisting with NMDAR antibodies), and 2 myasthenia without thymoma. Brain MRI was abnormal in 23 (88%) patients, showing in 20 (77%) multifocal, asynchronous, cortical-subcortical T2/fluid-attenuated inversion recovery abnormalities predominantly involving temporal (95%) and frontal (65%) lobes, but also basal ganglia and other regions. Immunologic or tumor therapy resulted in substantial improvement in 18/21 (86%) assessable patients; the other 3 (14%) died (2 status epilepticus, 1 sepsis). Compared with adults, children were more likely to have generalized seizures (p = 0.007) and movement disorders (p = 0.01) and less likely to have a tumor (p = 0.01). The main epitope targets were in the α1/β3 subunits of the GABAAR. CONCLUSIONS: Anti-GABAAR encephalitis is characterized by frequent seizures and distinctive multifocal cortical-subcortical MRI abnormalities that provide an important clue to the diagnosis. The frequency of symptoms and comorbidities differ between children (more viral-related) and adults (more tumor-related). The disorder is severe but most patients respond to treatment.
引用
- Spatola M, Petit-Pedrol M, Simabukuro MM, et al. Investigations in GABAA receptor antibody-associated encephalitis. Neurology. 2017. PMID: 28202703. doi:10.1212/WNL.0000000000003713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。